Towards evidence-based personalised precision medicine for Lynch syndrome
- PMID: 34478667
- DOI: 10.1016/S1470-2045(21)00400-9
Towards evidence-based personalised precision medicine for Lynch syndrome
Conflict of interest statement
We declare no competing interests. PM is principal investigator to the Prospective Lynch Syndrome Database (PLSD) and PLSD director on the European Hereditary Tumour Group board.
Comment on
-
A step closer to a personalised approach for Lynch syndrome.Lancet Oncol. 2021 Jul;22(7):899-901. doi: 10.1016/S1470-2045(21)00295-3. Epub 2021 Jun 7. Lancet Oncol. 2021. PMID: 34111420 No abstract available.